ETOPOSIDE (VP-16-213) - CURRENT STATUS OF AN ACTIVE ANTICANCER DRUG

被引：424

作者：

ODWYER, PJ

LEYLANDJONES, B

ALONSO, MT

MARSONI, S

WITTES, RE

机构：

来源：

关键词：

D O I：

10.1056/NEJM198503143121106

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：692 / 700

页数：9

共 147 条

[1] ETOPOSIDE - CHEMISTRY, PRE-CLINICAL AND CLINICAL-PHARMACOLOGY
ACHTERRATH, W
NIEDERLE, N
RAETTIG, R
HILGARD, P
[J]. CANCER TREATMENT REVIEWS, 1982, 9 : 3 - 13
[2] AHMANN DL, 1976, CANCER TREAT REP, V60, P633
[3] AISNER J, 1983, CANCER TREAT REP, V67, P37
[4] A PHASE-I TRIAL OF CONTINUOUS INFUSION VP16-213 (ETOPOSIDE)
AISNER, J
VANECHO, DA
WHITACRE, M
WIERNIK, PH
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 157 - 160
[5] AISNER J, 1980, CANCER, V46, P2543, DOI 10.1002/1097-0142(19801215)46:12<2543::AID-CNCR2820461202>3.0.CO
[6] 2-4
[7] AISNER J, 1982, CANCER CHEMOTH PHARM, V7, P187
[8] ANALYSIS OF 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY
ALLEN, LM
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) : 1440 - 1441
[9] ARNOLD AM, 1981, BRIT J CANCER, V43, P733
[10] ARNOLD AM, 1980, CANCER CHEMOTHER P S, V5, P2